China News Service, Haikou, March 30 (Reporter Zhang Qianyi) The reporter learned from the Hainan Provincial Medical Insurance Bureau on the 29th that Hainan will officially implement the ninth batch of nationally organized drug procurement results from 0:00 on March 30. The average price reduction of the ninth batch of centralized drug purchases organized by the state is as high as 58.65%. A total of 41 varieties have been implemented in this centralized purchase, which will save Hainan Province 20.11 million yuan in drug procurement. It will further reduce the burden of patients' medical expenses and increase the cost of centralized drug purchases. of accessibility.
It is understood that this centralized purchase involves a wide range of drugs, including drugs for the treatment of diabetes, allergic and autoimmune inflammation, gastrointestinal diseases and other common diseases. The prices of these drugs have dropped significantly after fierce bidding, providing patients with more economical and efficient medication options. Among them, voglibose, which is used to treat diabetes, has a specification of 0.2 mg. The price dropped from 1.032 yuan/piece before the centralized procurement to the selected price of 0.165 yuan/piece, a drop of up to 84.01%.
In addition, atomoxetine hydrochloride oral solution, which is clinically used to suppress nerve excitement and treat attention deficit hyperactivity disorder, the price of 0.4% (100mL: 0.4g) of the non-selected drugs on the Hainan website before the centralized procurement of this type of drugs is 380 yuan/piece. After being selected in the centralized procurement, the price of this product is only 15.51 yuan/piece, a decrease of approximately 95.92%. At the same time, the prices of drugs such as esomeprazole magnesium enteric-coated dry suspension for the treatment of gastrointestinal diseases have also been significantly reduced. The widespread application of these centralized and reduced-price drugs will bring benefits to more patients and reduce the burden on patients and the risk of poverty due to illness.
According to reports, to date, Hainan has participated in 13 batches of 9 batches of national centralized procurement, the National Alliance of Chinese Patent Medicines (the second batch of alliances for proprietary Chinese medicines led by Hubei) and 9 inter-provincial alliances, with more than 881 selected results of centralized procurement of medicines. Upon implementation, the average reduction in drugs exceeded 50%, and the average drug procurement completion rate exceeded 200%, saving approximately 3.6 billion yuan in procurement funds. (over)